These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29624457)

  • 21. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.
    Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Pogoda JM; Provost R; Guerrero J; Hajjar RJ; Zsebo KM
    Gene Ther; 2016 Mar; 23(3):313-9. PubMed ID: 26699914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
    Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
    Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive
    Kruzik A; Koppensteiner H; Fetahagic D; Hartlieb B; Dorn S; Romeder-Finger S; Coulibaly S; Weber A; Hoellriegl W; Horling FM; Scheiflinger F; Reipert BM; de la Rosa M
    Hum Gene Ther Methods; 2019 Apr; 30(2):35-43. PubMed ID: 30734588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy.
    Fu H; Meadows AS; Pineda RJ; Kunkler KL; Truxal KV; McBride KL; Flanigan KM; McCarty DM
    Hum Gene Ther Clin Dev; 2017 Dec; 28(4):187-196. PubMed ID: 29064732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay.
    Krotova K; Aslanidi G
    Hum Gene Ther; 2020 Oct; 31(19-20):1124-1131. PubMed ID: 32495655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies.
    Ito M; Takino N; Nomura T; Kan A; Muramatsu SI
    Sci Rep; 2021 Apr; 11(1):9322. PubMed ID: 33927271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
    Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
    Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing Antibodies Against Adeno-Associated Virus (AAV): Measurement and Influence on Retinal Gene Delivery.
    Desrosiers M; Dalkara D
    Methods Mol Biol; 2018; 1715():225-238. PubMed ID: 29188517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies.
    Kavita U; Dai Y; Salvador L; Miller W; Adam LP; Levesque PC; Zhang YJ; Ji QC; Pillutla RC
    Hum Gene Ther Methods; 2018 Dec; 29(6):237-250. PubMed ID: 30351228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preexisting Neutralizing Antibodies to Adeno-Associated Virus Capsids in Large Animals Other Than Monkeys May Confound In Vivo Gene Therapy Studies.
    Calcedo R; Franco J; Qin Q; Richardson DW; Mason JB; Boyd S; Wilson JM
    Hum Gene Ther Methods; 2015 Jun; 26(3):103-5. PubMed ID: 26067568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity.
    Adachi K; Dissen GA; Lomniczi A; Xie Q; Ojeda SR; Nakai H
    Sci Rep; 2020 Jun; 10(1):10073. PubMed ID: 32572045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions.
    Ling C; Wang Y; Feng YL; Zhang YN; Li J; Hu XR; Wang LN; Zhong MF; Zhai XF; Zolotukhin I; Srivastava A; Ling CQ
    J Integr Med; 2015 Sep; 13(5):341-6. PubMed ID: 26343106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue.
    Mingozzi F; Chen Y; Edmonson SC; Zhou S; Thurlings RM; Tak PP; High KA; Vervoordeldonk MJ
    Gene Ther; 2013 Apr; 20(4):417-24. PubMed ID: 22786533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior human hepatocyte transduction with adeno-associated virus vector serotype 7.
    Shao W; Pei X; Cui C; Askew C; Dobbins A; Chen X; Abajas YL; Gerber DA; Samulski RJ; Nichols TC; Li C
    Gene Ther; 2019 Dec; 26(12):504-514. PubMed ID: 31570819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
    Tseng YS; Gurda BL; Chipman P; McKenna R; Afione S; Chiorini JA; Muzyczka N; Olson NH; Baker TS; Kleinschmidt J; Agbandje-McKenna M
    J Virol; 2015 Feb; 89(3):1794-808. PubMed ID: 25410874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to circumvent humoral immunity to adeno-associated viral vectors.
    Tse LV; Moller-Tank S; Asokan A
    Expert Opin Biol Ther; 2015 Jun; 15(6):845-55. PubMed ID: 25985812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.
    Mimuro J; Mizukami H; Hishikawa S; Ikemoto T; Ishiwata A; Sakata A; Ohmori T; Madoiwa S; Ono F; Ozawa K; Sakata Y
    Mol Ther; 2013 Feb; 21(2):318-23. PubMed ID: 23247100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals.
    Mimuro J; Mizukami H; Shima M; Matsushita T; Taki M; Muto S; Higasa S; Sakai M; Ohmori T; Madoiwa S; Ozawa K; Sakata Y
    J Med Virol; 2014 Nov; 86(11):1990-7. PubMed ID: 24136735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.
    Mendoza SD; El-Shamayleh Y; Horwitz GD
    J Neurophysiol; 2017 May; 117(5):2004-2013. PubMed ID: 28202570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.